Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Triple Negative Breast Neoplasms

NCT04655183 2021-06-30

Study of M4344 in Combination With Niraparib

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT04464967 2021-05-12

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Phase 1/2 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT02336984 2021-01-11

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Phase 1/2 Withdrawn

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02547961 2020-07-16

Chimeric Antigen Receptor-Modified T Cells for Breast Cancer

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT03400254 2020-04-28

GLACIER

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT02713984 2020-03-19

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

Phase 1/2 Withdrawn

BreastCNSGastrointestinalGynecologicThoracic

Breast Neoplasms, Glioma, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT02018419 2020-01-22

MBC

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT03611985 2020-01-13

Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT02988648 2018-08-22

A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT03326258 2018-07-18

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Phase 1/2 Withdrawn

BreastDermatologic

Uveal Melanoma, Breast Neoplasms, Melanoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT00006123 2018-05-16

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT00769990 2017-12-13

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Phase 1/2 Withdrawn

BreastDermatologicGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pain, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT01361945 2017-05-09

AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT00397501 2017-04-21

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Phase 1/2 Withdrawn

BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01479179 2016-10-26

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT02396433 2015-08-25

Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT00022230 2015-05-05

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT00575978 2015-03-04

Hydralazine as Demethylating Agent in Breast Cancer

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT01614184 2013-07-10

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

Phase 1/2 Withdrawn

Breast

Breast Neoplasms

NCT00627627 2010-02-03

A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer

Phase 1/2 Withdrawn

56 enrolled

Breast

Breast Neoplasms

Clinical Trials

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer

A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients

Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

2019-101826

Study of SM-88 in Advanced Cancers

TOPAZ

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Study of M4344 in Combination With Niraparib

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Chimeric Antigen Receptor-Modified T Cells for Breast Cancer

GLACIER

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

MBC

Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients

A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Hydralazine as Demethylating Agent in Breast Cancer

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer